Harmony Biosciences Holdings, Inc. (HRMY)
39.64
+0.07
(+0.18%)
USD |
NASDAQ |
Oct 02, 16:00
39.64
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Net Income (Quarterly) : 75.43M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.43M |
| March 31, 2026 | 32.49M |
| December 31, 2025 | 22.49M |
| September 30, 2025 | 50.86M |
| June 30, 2025 | 39.78M |
| March 31, 2025 | 45.56M |
| December 31, 2024 | 49.48M |
| September 30, 2024 | 46.09M |
| June 30, 2024 | 11.59M |
| March 31, 2024 | 38.33M |
| December 31, 2023 | 26.61M |
| September 30, 2023 | 38.46M |
| June 30, 2023 | 34.30M |
| March 31, 2023 | 29.48M |
| December 31, 2022 | 48.51M |
| Date | Value |
|---|---|
| September 30, 2022 | 87.94M |
| June 30, 2022 | 23.53M |
| March 31, 2022 | 21.48M |
| December 31, 2021 | 22.71M |
| September 30, 2021 | -9.62M |
| June 30, 2021 | 14.12M |
| March 31, 2021 | 7.386M |
| December 31, 2020 | -0.208M |
| September 30, 2020 | 1.909M |
| June 30, 2020 | -0.027M |
| March 31, 2020 | -38.62M |
| December 31, 2019 | -36.44M |
| September 30, 2019 | -31.90M |
| June 30, 2019 | -20.62M |
| March 31, 2019 | -63.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Liquidia Corp. | 74.72M |
| Pfizer Inc. | -246.00M |
| Bristol Myers Squibb Co. | 3.316B |
| Repligen Corp. | 5.008M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 261.28M |
| Total Expenses (Quarterly) | 185.85M |
| EPS Diluted (Quarterly) | 1.284 |
| Enterprise Value | 1.857B |
| Gross Profit Margin (Quarterly) | 73.53% |
| Profit Margin (Quarterly) | 28.87% |
| Earnings Yield | 7.78% |
| Operating Earnings Yield | 9.91% |
| Normalized Earnings Yield | 7.785 |